Every SEC Form 3/4/5 on record for this filer (CIK 1763963) — 6 issuers, 42 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | Director | 2024-08-07 → 2026-06-23 | 5 | — |
| KLRA | Kailera Therapeutics, Inc. | Director | 2026-04-16 → 2026-04-20 | 2 | — |
| COR | Cencora, Inc. | Director | 2024-10-01 → 2026-03-09 | 5 | — |
| IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Chief Executive Officer · lapsed | 2022-02-18 → 2024-03-05 | 6 | — |
| MRK | Merck & Co., Inc. | EVP & Pres ? Human Health · lapsed | 2019-01-10 → 2021-11-04 | 16 | −$8M |
| DD | DuPont de Nemours, Inc. | Director · lapsed | 2019-06-05 → 2021-04-30 | 4 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
6 of 6 issuers are covered and open a security page; the rest are on file here only.